Chitin, Chitosan and Derivatives Market-Overview
The demand for novel materials has risen considerably to suit a growing range of applications, promoting the chitin, chitosan, and derivatives market. Reports created by MRFR detail the developments in the industry that can be expected in the market through the forecast period. The market is predicted to be motivated by a revenue of USD 8,987.8 Million by 2030 while the market grows at an 14.8% CAGR.
The ample availability of chitin is estimated to be a key factor estimated to create scope for its utilization, thus driving the chitin, chitosan and derivatives market. The food and beverage sector is estimated to contribute to a surge in the development of the chitin, chitosan and derivatives market.
Segmental Analysis
The segmentation of the chitin, chitosan and derivatives market is carried out on the basis of type, application and region. The application segment of the chitin, chitosan and derivatives market comprises of pharmaceuticals & nutraceuticals, food & beverages, animal feed, and agriculture. The type segment of the chitin, chitosan and derivatives market comprises of chitin, glucosamine, and chitosan. The regions included in the chitin, chitosan and derivatives market are North America, the Middle East, Asia Pacific, South America, Africa and Europe.
Detailed Regional Analysis
The Chitin, Chitosan, and Derivatives Market Overview includes regions such as North America, the Middle East, Asia Pacific, South America, Africa and Europe. The chitosan and derivatives market's North American region accounted for the chief market portion in 2018 while the regional market in the Asia Pacific is anticipated to list the highest CAGR in the forecast period. Rising health awareness and increasing understanding regarding the advantages of chitin, chitosan, and their byproducts are the important factors compelling the development of the North American chitin, chitosan and derivatives market. The incidence of many pharmaceutical and nutraceutical producers in the North American region is another influence boosting the eating of chitin, chitosan, and derivatives in the region, with the U.S. being the main national-level market.
Competitive Analysis
The Chitin, Chitosan, and Derivatives Market Size may show restrained development due to the second wave of COVID cases resurgence in several regions. The emphasis on creating reserves of resources to deal with unexpected situations is estimated to shape future market developments. The global market is estimated to see diversification in operating practices as newer models for operation and delivery come into place. The aid from government institutions is estimated to stimulate the global market's development in the coming years. The continuance of lockdowns intermittently in several regions may cause obstacles to the market's development as resources such as labour and supply chains to become seriously impacted. The innovations and research being undertaken in the market are estimated to create promising growth options in the coming period. The reliance on online commerce for sales is estimated to show a significant spike in the forecast period, leading to more investment in its development by market stakeholders.
The distinguished contenders in the chitin, chitosan and derivatives market are G.T.C. Bio Corporation (China), Zhejiang Candorly Pharmaceutical Co. (China), Heppe Medical Chitosan GmbH (Germany), Zhejiang Shinfuda Marine Biotechnology Corp. (China), Golden-Shell Pharmaceutical Co. Ltd. (China), Advanced Biopolymers AS (Norway), Kitozyme, L.L.C. (Belgium), Meron Group (India), Primex EHF (Iceland), and Panvo Organics Pvt Ltd (India).
Industry Updates:
Dec 2020 Pharmacists from RUDN University have revealed a formerly unknown derivative of chitin, a biopolymer that makes up the exoskeletons of carapaces of crayfish, insects and other arthropods. The novel compounds and their nanoparticles have antiseptic properties and are capable of catalyzing chemical reactions.
Sep 2020 A study led by Javier Fernandez and associates from Singapore University of Technology and Design has provided research that the bioinspired material, chitin, would be a feasible building substance for Mars inhabitation and tool manufacture. Fernandez has shared that by reverse-engineering chitin creation and merging it with an equivalent of Martian soil; a novel chitinous material was formed. This material named biolith has proven itself to be highly useful in making rigid forms by using minimal energy production.
May 2020 Experts at Nanyang Technological University, Singapore (NTU Singapore) have advanced a 'green way' to generate chitin, a fibrous substance comprising of polysaccharides which is the major component in the exoskeleton of arthropods and the cell membranes of fungi, by using two types of food waste such as prawn shells and discarded fruit and fermenting them.
